Literature DB >> 14561430

State-related thalamic changes during antipsychotic treatment in schizophrenia: preliminary observations.

Sasa Strungas1, James D Christensen, Jennifer M Holcomb, David L Garver.   

Abstract

Thalamic volumes and psychotic symptoms were assessed during psychotic exacerbation and during antipsychotic drug treatment. Reduction of psychotic symptoms (SAPS) during four weeks of treatment was highly correlated with volumetric expansion as measured by magnetic resonance imaging in both left and right thalamus [r(s)=0.75 and r(s)=0.82, respectively (both P<0.04)].

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14561430     DOI: 10.1016/s0925-4927(03)00092-1

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

Review 1.  Testing models of thalamic dysfunction in schizophrenia using neuroimaging.

Authors:  K Sim; T Cullen; D Ongur; S Heckers
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

Review 2.  Neuroimaging markers of antipsychotic treatment response in schizophrenia: An overview of magnetic resonance imaging studies.

Authors:  Goda Tarcijonas; Deepak K Sarpal
Journal:  Neurobiol Dis       Date:  2018-06-25       Impact factor: 5.996

3.  Predictive Biomarkers for Antipsychotic Treatment Response in Early Phase of Schizophrenia: Multi-Omic Measures Linking Subcortical Covariant Network, Transcriptomic Signatures, and Peripheral Epigenetics.

Authors:  Xiaofen Zong; Changchun He; Xinyue Huang; Jinming Xiao; Lei Li; Meiling Li; Tao Yao; Maolin Hu; Zhongchun Liu; Xujun Duan; Junjie Zheng
Journal:  Front Neurosci       Date:  2022-05-09       Impact factor: 5.152

4.  Clinical correlates of thalamus volume deficits in anti-psychotic-naïve schizophrenia patients: A 3-Tesla MRI study.

Authors:  Naren P Rao; Sunil Kalmady; Rashmi Arasappa; Ganesan Venkatasubramanian
Journal:  Indian J Psychiatry       Date:  2010-07       Impact factor: 1.759

5.  Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment?

Authors:  Ying Yue; Li Kong; Jijun Wang; Chunbo Li; Ling Tan; Hui Su; Yifeng Xu
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240

Review 6.  Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia.

Authors:  Giuseppe Caruso; Margherita Grasso; Annamaria Fidilio; Fabio Tascedda; Filippo Drago; Filippo Caraci
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-12

7.  Enlarged thalamic volumes and increased fractional anisotropy in the thalamic radiations in veterans with suicide behaviors.

Authors:  Melissa Lopez-Larson; Jace B King; Erin McGlade; Elliott Bueler; Amanda Stoeckel; Daniel J Epstein; Deborah Yurgelun-Todd
Journal:  Front Psychiatry       Date:  2013-08-12       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.